Ryvu Therapeutics SA (RVU) — Free Cash Flow Generation Index
Ryvu Therapeutics SA (RVU) has a Free Cash Flow Generation Index of 0.93x as of December 2022. Free cash flow of zł55.70 Million represents 1% of operating cash flow (zł59.92 Million). Explore RVU capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ryvu Therapeutics SA Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for Ryvu Therapeutics SA across 2 annual periods. For the full cash flow conversion analysis, see Ryvu Therapeutics SA (RVU) cash conversion ratio.
Annual Free Cash Flow Generation for Ryvu Therapeutics SA (2017–2022)
Year-by-year Free Cash Flow Generation Index for Ryvu Therapeutics SA. Check RVU capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (PLN) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.56x | zł12.03 Million | zł21.32 Million | zł9.29 Million | ▲ +158.6% |
| 2017 | -0.96x | zł-10.58 Million | zł10.98 Million | zł21.56 Million | — |